Noninvasive Transcutaneous Vagal Nerve Stimulation (tcVNS) for Neuromodulating the Conscious State

NCT ID: NCT07191340

Last Updated: 2025-09-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-31

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine whether noninvasive, transcutaneous vagal nerve stimulation (tcVNS) (Gammacore Sapphire Device) can help restore consciousness in patients in the Operating Room and Post Anesthesia Care Unit (PACU). To examine whether tcVNS administered in the PACU can help reduce delirium and depression post-surgery, speeding up cognitive recovery from anesthesia, and finally determine if tcVNS can expedite discharge from the PACU.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Delirium Depression Cognitive Function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Participant and outcomes assessor will not know which treatment arm the subject has been assigned to during the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group Stimulation of Vagus Nerve

Stimulation of the vagus nerve with nerve stimulator placed on neck

Group Type ACTIVE_COMPARATOR

Vagus nerve stimulator

Intervention Type DEVICE

Vagus nerve stimulator placed on neck and activated

Sham Placebo Group No Stimulation to Vagus Nerve

Nerve stimulator placed on neck but not activated.

Group Type PLACEBO_COMPARATOR

Placebo comparator sham

Intervention Type DEVICE

Vagus nerve stimulator placed on neck and not activated

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vagus nerve stimulator

Vagus nerve stimulator placed on neck and activated

Intervention Type DEVICE

Placebo comparator sham

Vagus nerve stimulator placed on neck and not activated

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged \> 18 years of age
* Patients undergoing lumbar surgery for degenerative disc disease or spinal stenosis involving two or more levels
* Mini-Mental State Examination (MMSE) score ≥ 15-accept mild
* Ability to use a keyboard
* Able to understand and communicate in English
* Be able to consent independently
* Women of child-bearing age must be comfortable confirming a negative pregnancy prior to participating in the study.
* Must not be involved in any other research intervention study testing neurobehavioral functioning
* Good internet connectivity and ability to use computer, smart phone or good telephone connectivity (follow up)

Exclusion Criteria

* Age \< 18 years of age
* History of vagotomy (cutting the vagus nerve)
* History of bradycardia, heart block, prolonged QT syndrome, brugada syndrome, heart failure with ejection fraction less than 35% and/or New York Heart Association symptoms
* MMSE \< 15
* History of seizure disorder or intracranial hemorrhage
* Patients with carotid stenosis
* Patients with aneurysms
* Other neurological diagnoses or a diagnosis of severe psychiatric disorder (e.g., psychosis) or a reported childhood learning disability
* Pregnancy, breastfeeding
* Active addiction history
* ECG adhesive allergy
* Severe aphasia, preventing subject from understanding the protocol and giving written consent
* Patients with an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
* Patients with metallic device such as a stent, bone plate or bone screw implanted at or near their neck
* Patients with an active implantable medical device, such as a pacemaker, hearing aid implant, or any implanted electronic device
* Patients with metallic device such as a stent, bone plate or bone screw implanted at or near their neck
* Patients who are using another device at the same time (e.g., transcutaneous electrical nerve stimulation (TENS) Unit, muscle stimulator) or any portable electronic device (e.g., mobile phone).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwestern University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alyson Engle, MD

Role: PRINCIPAL_INVESTIGATOR

Northwestern Univesity

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU00217188

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Transauricular Vagus Nerve Stimulation in Children
NCT06168071 ENROLLING_BY_INVITATION NA
Post-stroke Pain taVNS
NCT06456385 COMPLETED NA